Elotuzumab Market
There were few treatment options for RRMM aIntroduction vailable before to elotuzumab, and relapse rates were significant. Elotuzumab provided a novel strategy by focusing on a particular immunological route, which strengthened the body's defenses against myeloma cells. Clinical trials demonstrated that elotuzumab, in combination with lenalidomide and dexamethasone...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian